Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 28;23(9):128.
doi: 10.1007/s11886-021-01549-5.

Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments

Emanuele Bizzi  1 , Lucia Trotta  2 , Massimo Pancrazi  2 , Mariangela Nivuori  2 , Valeria Giosia  2 , Luca Matteucci  2 , Daniela Montori  2 , Antonio Brucato  3
Affiliations
Review

Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments

Emanuele Bizzi et al. Curr Cardiol Rep. .

Abstract

Purpose of the review: The purpose of the review is to analyze the pathogenetic mechanisms that underlie acute pericarditis, with attention to autoimmune and autoinflammatory pericarditis, and, in addition, to review the available therapeutic armamentarium.

Recent findings: Several studies have been published on the use of anti-IL-1 drugs in recurrent pericarditis, including anakinra and rilonacept. The latest, the RHAPSODY study, based on the use of rilonacept in recurrent pericarditis, has recently reached phase 3 with promising results in terms of efficacy and safety. Alterations in the function of the inflammasome and the consequent overproduction of IL-1 play a pivotal role in the genesis of autoinflammatory pericarditis. Recent studies added evidence to the importance of anti-IL-1 drugs in the treatment of recurrent pericarditis with raised C-reactive protein. In the era of tailored medicine, anti-IL-1 agents may be very useful in the subset of patients with recurrent pericarditis and a clear inflammatory phenotype.

Keywords: Anakinra; Interleukin 1; Pericarditis; Recurrent pericarditis; Rilonacept.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Snyder MJ, Bepko J, White M. Acute pericarditis: diagnosis and management. Am Fam Physician. 2014;89(7):553–60. - PubMed - PMC
    1. Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: a systematic review. JAMA. 2015;314(14):1498–506. - PubMed - DOI - PMC
    1. Imazio M, Battaglia A, Gaido L, Gaita F. Recurrent pericarditis. Rev Med Interne. 2017;38(5):307–11. - PubMed - DOI - PMC
    1. Imazio M, Brucato A, Derosa FG, Lestuzzi C, Bombana E, Scipione F, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown). 2009;10(3):217–30. - DOI
    1. Doctor NS, Shah AB, Coplan N, Kronzon I. Acute pericarditis. Prog Cardiovasc Dis. 2017;59(4):349–59. - PubMed - DOI - PMC

MeSH terms

Substances

LinkOut - more resources